ArticleFrontiers in oncology2026

Neoadjuvant camrelizumab in combination with chemotherapy followed by sequential radical surgery for locally advanced esophageal squamous cell carcinoma: postoperative pathological remission characteristics and influencing factors.

Jiaxin Pei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.